Cargando…
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
BACKGROUND: Although otorrhea occurs commonly in HIV-infected infants, there are few data. We compared the incidence of otorrhea in infants receiving early vs deferred ART in the Children with HIV Early Antiretroviral (CHER) trial. Infants aged 6 to 12 weeks of age with confirmed HIV infection and a...
Autores principales: | Hainline, Clotilde, Taliep, Reghana, Sorour, Gill, Nachman, Sharon, Rabie, Helena, Dobbels, Els, van Rensburg, Anita Janse, Cornell, Morna, Violari, Avy, Madhi, Shabir A, Cotton, Mark F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219790/ https://www.ncbi.nlm.nih.gov/pubmed/22029910 http://dx.doi.org/10.1186/1756-0500-4-448 |
Ejemplares similares
-
Five year neurodevelopment outcomes of perinatally HIV‐infected children on early limited or deferred continuous antiretroviral therapy
por: Laughton, Barbara, et al.
Publicado: (2018) -
Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?
por: Innes, Steve, et al.
Publicado: (2014) -
Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
por: Lewis, Joanna, et al.
Publicado: (2017) -
Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy
por: Johansson, Kjell Arne, et al.
Publicado: (2010) -
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
por: Dharan, Nila J., et al.
Publicado: (2019)